FOSFONOL

Welcome to the Brand page for “FOSFONOL”, which is offered here for Full line of pharmaceutical preparations for protection against and treatment of mutagenesis, radiation injury, side-effects of radiation therapy and chemotherapy, and carcinogenesis;.

Its status is currently believed to be active. Its class is unavailable. “FOSFONOL” is believed to be currently owned by “Hollis-Eden Pharmaceuticals, Inc.”

Owner:
HOLLIS-EDEN PHARMACEUTICALS, INC.
Owner Details
Description:
Full line of pharmaceutical preparations for protection against and treatment of mutagenesis, radiation injury, side-effects of radiation therapy and chemotherapy, and carcinogenesis;
Categories: FULL LINE PHARMACEUTICAL PREPARATIONS